Sabinsa granted US patent for synbiotic composition of shelf-stable probiotic and cranberry fibers
18 Sep 2017 --- Sabinsa has been granted a US patent on the company’s shelf-stable probiotic LactoSpore in combination with cranberry seed fibers. The granted patent (US9717766) discloses a method of increasing the viable colony count of Bacillus coagulans MTCC 5856 in a synbiotic composition containing natural plant fibers from Vaccinium oxycoccos (cranberry). The cranberry fibers in this composition were observed to increase the viable count of Bacillus coagulans MTCC 5856.
This combination product is sold under the name LactoCran, with the cranberry seed fiber components supplied by Fruit d'Or Nutraceuticals of Quebec, Canada. LactoCran provides support for healthy gut and digestive health. The non-lactose, dairy-free, non-GMO combination works well in sports nutrition supplements as it contains a rich composition of 16 essential amino acids and 8 branch chain amino acids.
“LactoCran will soon be available in cranberry flavored gummies as well as peanut butter cups,” Anurag Pande, Sabinsa Vice President of Scientific Affairs, tells NutritionInsight.
This patent, along with the previously granted patent for the management of irritable bowel syndrome, is expected to boost LactoSpore’s popularity and market value, the company reports.
LactoSpore is a generally recognized as safe (GRAS) probiotic containing Bacillus coagulans MTCC 5856, which is lactose-free and non-GMO. The probiotic is room temperature stable and does not require refrigeration, ensuring a long product shelf life. Because of its ability to withstand high heat, LactoSpore has also been included in functional baked goods. Clinically studied LactoSpore can be used in a variety of food and dietary supplements for maintaining gut health and good microbiota, the Sabinsa press release points out.
In related news, Sabinsa President-Worldwide Shaheen Majeed recently spoke to NutritionInsight about curcumin and other trending nutritionals.
By Lucy Gunn
